Sphera Funds Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
2020
Q1
$299K Sell
2019
Q4
$723K Hold
2019
Q3
$1.54M Buy
2017
Q4
Sell
2017
Q3
$217K Sell
2017
Q2
$522K Buy
2017
Q1
$513K Hold
2016
Q4
$453K Buy
2015
Q3
Sell
2015
Q2
$3.72M Sell
2015
Q1
$3.19M Buy